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• Total    = 52.8 Million Deaths  
NCDs =  34.5 Million
• Communicable, Maternal, Neonatal and 
Nutritional causes = 24.9% 
(Down From 34.1% in 1990)
• Non-Communicable Diseases =65.3%           
(Up From 57% in 1990)
Mortality
Causes of death (GBD 2010) 
http://www.healthmetricsandevaluation.org/gbd/visualizations/gbd-arrow-diagram
Developed Countries
Causes of death (GBD 2010) 
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Developing Countries



NCDs & ECONOMIC DEVELOPMENT
(HIC vs LMIC)
 Proportional Mortality Is Higher in HIC
 Absolute Mortality Is Higher in LMIC
BUT
 Age Standardised Mortality Rates Are 
Also Higher In LMIC!
Cardiovascular disease
(Age-standardized death rate per 100 000, males)
Yach D., 2009
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More people die from heart diseases and strokes in the 
poorest developing countries  than in the richest industrialized 
countries
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Global Burden of Cancer
 14 million new cases in 2012; expected to rise 
to 22 million cases in next two decades
 More than 60% of the world’s total cases occur 
in Africa, Asia, and Central and South America, 
and these regions account for about 70% of the 
world’s cancer deaths
 Total annual economic cost of cancer in 2010 
was estimated at approximately US$ 1.16 
trillion World Cancer Report; 2014
Is NCD an issue for poor countries? YES!
Source: Beaglehole R, Bonita R, Alleyne G, et al for the Lancet NCD Action group UN HLM on NCDs: Addressing four 
questions. Lancet 2011; POL June 13 2011
The Rising NCD Challenge In Developing Regions Including 
Younger Populations
Source: World Bank, 2011
GLOBAL VARIATION IN STROKE AND CHD
 Stroke burden disproportionately higher in China, Africa and 
South America
 CHD mortality higher in Middle East, North America, 
Australia and much of Europe
 Lower national income was associated with higher relative 
mortality and burden of disease from stroke.
 Diabetes mellitus and mean serum cholesterol associated 
with higher relative burden of CHD, even after adjustment for 
national income
Kim AS, Johnston C. Circulation, 2011
Why are different countries 
showing different patterns of 
CVD?
• Rise/Fall of Mortality Rates
• CHD/Stroke As Dominant CVD
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VALUE?
• Health Transition Model Provides An Evolving 
Perspective Instead Of A Limited Cross-Sectional View
• It Helps To Anticipate The Epidemic And Provide A 
Proactive Preventive Response 
BUT
• It Is Dominated By Proportional Mortality And Ignores 
Age Standardised Mortality Rates
• It Is Not Likely To Be A Simple Linear Model. Complex 
Systems Are Non-Linear
Transitions That Shape Public Health
1.Demographic 5.Economic
2.Epidemiologic 6.Energy
3.Urban 7.Biological, Ecological
4.Nutritional 8.Cultural
9.Democratic
Rayner G, Lang T. Public health and nutrition. Our vision: Where do we go? World Nutrition April 2012 
“ Do we not always find the diseases of the 
populace  traceable to defects in society?” 
“If disease is an expression of individual life 
under unfavorable circumstances, then 
epidemics must be indicative of mass 
disturbances.”
- Rudolf Virchow
• Demographic Shifts (Aging)
• Urbanization
• Industrialisation
• Globalization                (Marketing)
• Education
• Culture
• Poverty                        (Access to Health)
• Built Environment        (Barrier/Enabler)
Vectors : Tobacco; Unhealthy Food; Alcohol
DETERMINANTS
(Living Habits) 
(Beliefs) 
Global Challenge of NCDs
APATHY (2000)
ATTENTION (2011)
ACTION ?
MYTHS DISPELLED; EVIDENCE AUGMENTED
NOW IS THE TIME FOR ACTION
• NCDs are NOT the problem of only rich 
countries
• NCDs are NOT the problem of only the 
elderly
• NCDs also impose a huge economic 
burden in all regions of the world
• Risk factors of NCDs are rising across the 
world. To contain them is…

POTENTIALLY PRODUCTIVE YEARS OF LIFE LOST        
DUE TO CARDIOVASCULAR DEATHS 
(AGE GROUP : 35-64 YEARS )
25
1.6
3.3
6.7
9.2
2.0
3.2
10.5
17.9
USARussiaChinaIndia
In Millions
2030
2000
Estimated Economic Loss for India due to 
Heart Disease, Stroke and Diabetes (2005-2015) : US $ 237 Billion  - WHO
The World Bank Stand on NCDs 
(1999)
Article Title: The burden of disease among the global poor
Authors: Gwatkin DR,  Guillot M, Heuveline P
Publication: Lancet 1999; 354: 586-89
Method: Comparison of disease burdens in the richest 20% and   
poorest 20%
“A faster decline in communicable diseases would 
decrease the poor-rich gap in 2020, but under an 
accelerated rate of overall decline in non-communicable 
diseases, the poor-rich gap would widen”
The World Bank on NCDs (2007)
“To what extent do NCDs affect the poor? The 
answer depends to some extent on the country 
and the indicator of the NCD burden that is 
considered.  However, in all countries and by any 
metric, NCDs account for a large enough share of 
the disease burden of the poor to merit a serious 
policy response.”

NCDs: Economic Impact
 NCDs accounted for five of the six top 
causes of economic loss in 2008
 Heart  disease :  $752bn
 Stroke:                 $298bn
 Diabetes:            $204bn
NCDs cost developing countries between 0.02% to 6.77% 
of GDP; this economic burden is more than that caused 
by Malaria (1960’s) or AIDS (1990’s) - IOM Report 2010
NCDs will lead to a loss of 30 Trillion Dollars globally up 
to 2030 representing 48% of global GDP in 2010; with 
mental health added loss rises to 47 trillion dollars –
Harvard + WEF Study 2011
NCDs are the third largest global risk in terms of likelihood and 
the fourth largest global risk in terms of economic severity
World Economic Forum: 
Global Risk 2010 Report
Oil spikes
Retrenching from globalization
Asset price collapse
Food price volatility
Financial crisis
Noncommunicable diseases
Infectious diseases
"A problem neither the 
developed world nor the 
developing world can afford"
(WEF Global Risk 2010 Report)
UN-WHO Targets For NCDs
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Most are related to risk factors of NCDs
25 by 25
GBD 2010 
Lancet 2012
Risk Factors
(Top Contributors to DALYs)
1. High Blood Pressure
2. Smoking (excluding SHS)
3. Alcohol Use
4. Household Air Pollution
5. Low Fruit
6. High Body Mass Index
7. High Fasting Plasma Glucose
8. Childhood Underweight
9. Ambient PM Pollution
10 Physical Inactivity
Diet & Physical 
Inactivity Cluster 
Responsible For 
Largest Global 
Disease Burden
(Ezzati & Riboli, NEJM 2013)
RISK FACTORS FOR NCDs
RISK FACTOR CHANGE: EZZATI ESTIMATES 
(1980-2008)
Blood Pressure
 Fell in North America, Australasia, Western 
Europe 
 Rose in Oceania, East Africa, South Asia, 
South East Asia (and West African Women)
 SBP is currently highest in low and middle 
income countries
Source : Danaei G et al. Lancet, 2011

Snack imports from the United States into Central 
America, 1989-2006
Source: FAO 2007
RISK FACTOR CHANGE: EZZATI ESTIMATES 
(1980-2008)
Cholesterol
 Fall in Australasia, North America, Western 
Europe, Central and Eastern Europe
 Increase in East and South East Asia and 
Pacific 
 Highest in high income countries
 Lowest in Sub-Saharan Africa
Source: Farzadfar F et al. Lancet, 2011
Mean Plasma Cholesterol Values in China
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EVOLUTION OF 
HOMO ROTUNDUS!
Changes in the Prevalence (%) of Overweight 
and Obesity in Mexican Adults
Source: Barquera et al; 2009
Obesity: Ezzati Estimates
 Globally: 10 % of men were obese in 2008 
4.8% in 1980
 Globally: 14 % of women were obese in 2008 
7.9 % in 1980
 Pacific islands has the highest mean BMI 
Men: 34; Women: 35
 Lowest mean BMI among DR Congo Men (19.9) 
and Bangladesh Women (20.5)
 USA 
 highest average BMI among high-income countries, 
 most rapid increase in BMI in the last 30 yrs 
 Increase in 1 BMI point per decade
Finucane et al., Lancet 2011; 377: 557–67
Low birth weight and its 
consequences
Rebound 
Adiposity
Hypertension
Coronary  
heart disease
Atherosclero
sis, 
Stroke
Type II Diabetes, 
Insulin resistance
Adult lung 
function
? Cancer
Risk factors: tobacco use on the rise in 
developing countries
Does Ethnicity Matter?
While ethnic comparison studies do suggest 
that some ethnic groups are at a higher risk of 
manifesting CHD (e.g; South Asians)        or 
Stroke (East Asians; Africans), 
MIGRANT STUDIES SUGGEST THAT 
ENVIRONMENT IS THE DOMINANT FACTOR IN 
THE EXPRESSION OF RISK 
INTERHEART Study
•About 90% of CHD Risk (“PAR”) can be explained by 
9 Risk Factors:
• Smoking
• Diabetes
• Hypertension  
• Abdominal Obesity 
• Psychosocial Factors 
• Fruits & Vegetables 
• Exercise 
• Alcohol 
• Apo B/Apo A1 ratio
Yusuf et al, The Lancet, 364: 937 - 952, Sept 2004 
46
THE TASK BEFORE US
Stage I       Stage II Stage III       Stage IV       ?
Avoid /Abbreviate the Stage of Mid-Life Death and Disability
RESPONSE TO HEALTH TRANSITION
Low Risk High Risk
POPULATIONS
Demographic and Social Determinants
Public Health Interventions
Low Risk High Risk
INDIVIDUALS
Biology + Beliefs + Behaviors
Clinical + Behavioral Interventions
Address the bulk of the distribution 
through small shifts             
(Population Attributable Risk)
POPULATION BASED
Address the individuals at the highest 
‘absolute’ risk of a CVD event 
(Comprehensive Cardiovascular Risk)
+
CVD PREVENTION
HIGH RISK 
Widespread Effect = Large Benefits High Impact = Cost-Effective use of resources
% Decline in CHD Deaths Attributed to Interventions
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Iceland Sigfusson 68-88
Finland Vartiainen 72-92
New Zealand Beaglehole 74-81
USA Goldman 68-76
Holland Bots 78-85
USA Hunink 80-90
Scotland 75-94
New Zealand 82-93
England-Wales 81-00 
Treatments Risk factors
Capewell S et al.,Circulation 2000;102:1511-6. 
50
GLOBAL RESPONSE
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Power of Policy
• Modifies social and economic determinants of 
behaviours
 Influences how people Eat, Smoke, Drink, Move
• Creates enabling environment to initiate & maintain 
behaviour change in communities and individuals
• Can impact on multiple risk factors simultaneously
• Reduces population risk in short time
• Cost effective
• Relatively easy to implement
• Has intergenerational benefit
POWER OF POLICY                               
FOR CHRONIC DISEASE PREVENTION
TOBACCO
Evidence is available from many countries                  
(including LMIC) that 
- Taxation
- Ad Bans
- Smoke Free Policies
- Health Warnings                                                   
ARE EFFECTIVE 
48.1% of mortality averted in UK (1981-2000) is attributable to reduced smoking
(Unal B et al. Circulation 2004)
Smoke Free Policies and Myocardial 
Infarction (MI)
Study and location % decrease in MI 
admission rates
Sargent et al, 2004, Helena, USA 40
Bartecchi et al, 2006, Pueblo, USA 27
Barone –Adesi et al, 2006, Piedmont, Italy 11
Seo et al, 2007, Monroe, Indiana, USA 29
Khuder et al, 2007, Bowling Green, Ohio, USA 47
Juster et al, 2007, New York, USA 8
Lemstra et al, 2008, Saskatoon, Canada 13
Cesaroni et al, 2008, Rome, Italy 8
Pell et al, 2008, Scotland 17
Edwards et al, 2008, New Zealand No change
Vasseli et al, 2008, Four  regions of Italy 13
CDC, 2009, Pueblo, USA 41
Meyers et al., 2009, Meta-analysis 17
Impact of Taxation on Cigarette Sales; 
France & South Africa
‘’Triple-Halve-Double’’; Tripling of cigarette prices halved the consumption and 
doubled the inflation adjusted Government revenue.
- Source: Hill et al, 2010 & Van Walbeek, 2006
POWER OF POLICY FOR CHRONIC DISEASE 
PREVENTION 
DIET
• Evidence of preventive potential of policy 
interventions available from 
 Mauritius (Price of Edible Oils)
 Poland (Import of F-V and Healthy Fats)
 Finland (Farming; Marketing; Community Education)
New Initiatives
• Food Labeling
• Reduced Salt in Processed Foods
• Ban on Trans-Fats
• Advertising Restrictions
   CVD & risk factors
 Intensive national CVD intervention programme to 
reduce risk factors
 extensive mass media 
 fiscal & legislative measures
 diverse settings: community, school & workplace
Government intervention: Subsidized cooking oil
(unsaturated) Soya bean oil instead of (saturated) fat rich palm oil
 Adult mean total cholesterol level decreased  during 1987-1992 from 
5.5 to 4.7 mmol/l ( 15%)
Dowse G et al., BMJ 1995;311:1255-9.
Mauritius
Dietary Change and CHD Mortality
in Poland
Zatonski W et al., BMJ 1998;316:1047-51
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Policy Measures (Usually) 
Do Not Cost The Government Money
- Tobacco Taxes
- Ad Bans
- Public Smoking Bans
- Regulation of Processed Food (eg., Salt, Trans Fats)
- Food Labeling
Access to Drugs
36 country WHO study: 
 Availability of CVD (atenolol, captopril, hydrochlorothiazide, 
losartan, nifedipine) drugs varied considerably across countries
 Overall availability was poor-
26% in public sector, 57% private sector
 Cost fluctuation between countries, with patient prices generally 
higher than international references prices
van Mourik M et al. BMC Cardiovasc Disord 2010;10:25.  
1. Enhancing capacity for generic substitution
2. Expediting generic availability by overcoming legal barriers related 
to patents licenses
3. Optimizing local procurement practices  in the public sector
4. Broadening global procurement via third-party price negotiations
5. Engaging the private sector to differentially price CVD medicines in LMICs
6. Regulating retail mark-ups in the supply chain 
Improving Access to Drugs
7.  Eliminating tariffs on medicines
8. Developing a fixed-dose combination (FDC) for CVD (the ‘Polypill’)  
MOVING BEYOND NCDs
 CCI = Chronic Conditions & Injuries
 Health Systems Strengthening 
 Universal Health Coverage
 Sustainable Development (post 2015)
Global action on NCDs calls for stronger 
partnerships and wider arena of action
GLOBAL NATIONAL COMMUNITY FAMILY INDIVIDUAL
Development
(stage and speed)
Distribution
(equity)
Demand- Supply
(trade)
Beliefs
Behaviours
Biology
Perceptions
(cultural)
Priorities
(socio-economic)
Pathways
(availability, access)
RISK CASCADE OF NCDs
HEALTH BEYOND HEALTH CARE
“ Health leaps out of Science and draws 
nourishment from the Society around it”
‐ Gunnar Myrdal
(Swedish Economist, Nobel Laureate)
POLICIES AND PROGRAMMES IN 
• Finance • Water • Sanitation • Agriculture • Food Processing 
• Education • Rural Development • Urban Design • Transport 
• Communications • Trade • Environment
NEED TO BECOME SENSITIVE AND RESPONSIVE TO 
PUBLIC HEALTH CONCERNS !
POLICY APPROACHES
(Global; National; Local)
Financial TradeRegulatoryLegal
Environment To Enable Individuals To Make 
and Maintain Healthy Choices
INDIVIDUAL
FAMILY
NEIGHBORHOOD, COMMUNITY
Enhancement of Knowledge, Motivation, and 
Skills of Individuals
Media Settings BasedCommunity Interventions
HEALTH COMMUNICATION
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